🇺🇸 FDA
Patent

US 11885861

3-dimensional representations of post-contrast enhanced brain lesions

granted A61KA61K49/106

Quick answer

US patent 11885861 (3-dimensional representations of post-contrast enhanced brain lesions) held by The Board of Regents of the University of Texas System expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K49/106